BML-190 (cas 2854-32-2) and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates
-
Add time:07/15/2019 Source:sciencedirect.com
The aminoalkylindole BML-190 (cas 2854-32-2) and diarylpyrazole AM251 ligands have previously been shown to bind to cannabinoid CB2 and CB1 receptors, respectively. In HEK-293 cells stably expressing the human CB2 receptor, BML-190 and AM251 potentiated the forskolin-stimulated accumulation of cAMP. Moreover, the CB2 receptor can interact productively with 16z44, a promiscuous Gα16/z chimera. BML-190 and AM251 reduce the basal levels of inositol phosphate production in cells expressing the CB2 receptor and 16z44. These results demonstrate that BML-190 and AM251 act as inverse agonists at the human CB2 receptor acting via Gαi/o and Gαq family-coupled pathways.
We also recommend Trading Suppliers and Manufacturers of BML-190 (cas 2854-32-2). Pls Click Website Link as below: cas 2854-32-2 suppliers
Prev:The first silver(I) nitrate π-complexes with unsaturated organosilicons: Synthesis and structural characterization of [Ag(DADPS)xNO3] (DADPS = DIALLYLDIPHENYLSILANE (cas 10519-88-7), x = 0.75; 1)
Next:In vitro metabolism of indomethacin morpholinylamide (BML-190 (cas 2854-32-2)), an inverse agonist for the peripheral cannabinoid receptor (CB2) in rat liver microsomes) - 【Back】【Close 】【Print】【Add to favorite 】